Generation of neural cells from DM1 induced pluripotent stem cells as cellular model for the study of central nervous system neuropathogenesis

Cellular Reprogramming

Volumn 15, Issue 2, 2013, Pages 166-177

  Xia, Guangbin ^a   Santostefano, Katherine E ^a   Goodwin, Marianne ^a   Liu, Jilin ^a   Subramony, S H ^a   Swanson, Maurice S ^a   Terada, Naohiro ^a   Ashizawa, Tetsuo ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASTROCYTE; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL LINE; CELL LINEAGE; CLONE; CONTROLLED STUDY; CYTOPLASM; EMBRYONIC STEM CELL; GERM LAYER; HUMAN; HUMAN CELL; MYOTONIC DYSTROPHY; NEURAL STEM CELL; NEUROPATHOLOGY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL;

CELL DIFFERENTIATION; CELL LINE; DERMIS; FEMALE; FIBROBLASTS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MALE; MIDDLE AGED; MYOTONIC DYSTROPHY; NEURAL STEM CELLS; STEM CELL TRANSPLANTATION;

EID: 84875949817     PISSN: 21524971     EISSN: 21524998     Source Type: Journal    
DOI: 10.1089/cell.2012.0086     Document Type: Article

References (67)

1. Ashizawa, T., and Sarkar, P.S. (2011). Myotonic dystrophy types 1 and 2. Handb. Clin. Neurol. 101, 193-237.
2. Baharvand, H., Totonchi, M., Taei, A., Seifinejad, A., Aghdami, N., and Salekdeh, G.H. (2010). Human-induced pluripotent stem cells: Derivation, propagation, and freezing in serum-and feeder layer-free culture conditions. Methods Mol. Biol. 584, 425-443.
3. Bird, T.D., Follett, C., and Griep, E. (1983). Cognitive and personality function in myotonic muscular dystrophy. J. Neurol. Neurosurg. Psychiatry 46, 971-980.
4. Blum, B., and Benvenisty, N. (2009). The tumorigenicity of dip-loid and aneuploid human pluripotent stem cells. Cell Cycle 8, 3822-3830.
5. Charizanis, K., Lee, K.Y., Batra, R., Goodwin, M., Zhang, C., Yuan, Y., Shiue, L., Cline, M., Scotti, M.M., Xia, G., Kumar, A., Ashizawa, T., Clark, H.B., Kimura, T., Takahashi, M. P., Fu-jimura, H., Jinnai, K., Yoshikawa, H., Gomes-Pereira, M., Gourdon, G., Sakai, N., Nishino, S., Foster, T. C., Ares, M., Jr., Darnell, R.B., and Swanson, M.S. (2012). Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy. Neuron 75, 437-450.
6. de Leon, M.B., and Cisneros, B. (2008). Myotonic dystrophy 1 in the nervous system: from the clinic to molecular mechanisms. J. Neurosci. Res. 86, 18-26.
7. Dhaenens, C.M., Schraen-Maschke, S., Tran, H., Vingtdeux, V., Ghanem, D., Leroy, O., Delplanque, J., Vanbrussel, E., Dela-courte, A., Vermersch, P., Maurage, C.A., Gruffat, H., Sergeant, A., Mahadevan, M.S., Ishiura, S., Buee, L., Cooper, T.A., Caillet-Boudin, M.L., Charlet-Berguerand, N., Sablonniere, B., and Sergeant, N. (2008). Overexpression of MBNL1 fetal iso-forms and modified splicing of Tau in the DM1 brain: Two individual consequences of CUG trinucleotide repeats. Exp. Neurol. 210, 467-478.
8. Dhaenens, C.M., Tran, H., Frandemiche, M.L., Carpentier, C., Schraen-Maschke, S., Sistiaga, A., Goicoechea, M., Eddar-kaoui, S., Van Brussels, E., Obriot, H., Labudeck, A., Gevaert, M. H., Fernandez-Gomez, F., Charlet-Berguerand, N., Dera-mecourt, V., Maurage, C.A., Buee, L., de Munain, A.L., Sa-blonniere, B., Caillet-Boudin, M.L., and Sergeant, N. (2011). Mis-splicing of Tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing. Biochim. Biophys. Acta 1812, 732-742.
9. Douniol, M., Jacquette, A., Guile, J.M., Tanguy, M.L., Angeard, N., Heron, D., Plaza, M., and Cohen, D. (2009). Psychiatric and cognitive phenotype in children and adolescents with myotonic dystrophy. Eur. Child Adolesc. Psychiatry 18, 705-715.
10. Ekstrom, A.B., Hakenas-Plate, L., Samuelsson, L., Tulinius, M., and Wentz, E. (2008). Autism spectrum conditions in myo-tonic dystrophy type 1: A study on 57 individuals with congenital and childhood forms. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B, 918-926.
11. Fu, Y.H., Pizzuti, A., Fenwick, R.G., Jr., King, J., Rajnarayan, S., Dunne, P.W., Dubel, J., Nasser, G.A., Ashizawa, T., de Jong, P., et al. (1992). An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255, 1256-1258.
12. Furling, D., Doucet, G., Langlois, M.A., Timchenko, L., Belanger, E., Cossette, L., and Puymirat, J. (2003). Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions. Gene Ther. 10, 795-802.
13. Gomes-Pereira, M., Cooper, T.A., and Gourdon, G. (2011). Myotonic dystrophy mouse models: Towards rational therapy development. Trends Mol. Med. 17, 506-517.
14. Harper, P. (2001). Myotonic Dystrophy, 3rd ed. London: WB Saunders.
15. Hockemeyer, D., and Jaenisch, R. (2010). Gene targeting in human pluripotent cells. Cold Spring Harb. Symp. Quant. Biol. 75, 201-209.
16. Hockemeyer, D., Soldner, F., Beard, C., Gao, Q., Mitalipova, M., DeKelver, R.C., Katibah, G.E., Amora, R., Boydston, E.A., Zeitler, B., Meng, X., Miller, J.C., Zhang, L., Rebar, E.J., Gregory, P.D., Urnov, F.D., and Jaenisch, R. (2009). Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat. Biotechnol. 27, 851-857.
17. Hockemeyer, D., Wang, H., Kiani, S., Lai, C.S., Gao, Q., Cassady, J.P., Cost, G.J., Zhang, L., Santiago, Y., Miller, J.C., Zeitler, B., Cherone, J.M., Meng, X., Hinkley, S.J., Rebar, E. J., Gregory, P.D., Urnov, F.D., and Jaenisch, R. (2011). Genetic engineering of human pluripotent cells using TALE nucleases. Nat. Bio-technol. 29, 731-734.
18. Izpisua Belmonte, J.C., Ellis, J., Hochedlinger, K., and Yamana-ka, S. (2009). Induced pluripotent stem cells and reprogram-ming: Seeing the science through the hype. Nat. Rev. Genet. 10, 878-883.
19. Jiang, H., Mankodi, A., Swanson, M.S., Moxley, R.T., and Thornton, C.A. (2004). Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of mu-scleblind proteins and deregulated alternative splicing in neurons. Hum. Mol. Genet. 13, 3079-3088.
20. Kanadia, R.N., Urbinati, C.R., Crusselle, V.J., Luo, D., Lee, Y.J., Harrison, J.K., Oh, S.P., and Swanson, M.S. (2003). Developmental expression of mouse muscleblind genes Mbnl1, Mbnl2 and Mbnl3. Gene Expr. Patterns 3, 459-462.
21. Kiuchi, A., Otsuka, N., Namba, Y., Nakano, I., and Tomonaga, M. (1991). Presenile appearance of abundant Alzheimer's neurofibrillary tangles without senile plaques in the brain in myotonic dystrophy. Acta Neuropathol. 82, 1-5.
22. Kiuru, M., Boyer, J.L., O'Connor, T.P., and Crystal, R.G. (2009). Genetic control of wayward pluripotent stem cells and their progeny after transplantation. Cell Stem Cell 4, 289-300.
23. Langlois, M.A., Lee, N.S., Rossi, J.J., and Puymirat, J. (2003). Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts. Mol. Ther. 7, 670-680.
24. Larsen, J., Pettersson, O.J., Jakobsen, M., Thomsen, R., Pedersen, C.B., Hertz, J.M., Gregersen, N., Corydon, T.J., and Jensen, T.G. (2011). Myoblasts generated by lentiviral mediated MyoD transduction of myotonic dystrophy type 1 (DM1) fibroblasts can be used for assays of therapeutic molecules. BMC Res. Notes 4, 490.
25. Lee, J.E., and Cooper, T.A. (2009). Pathogenic mechanisms of myotonic dystrophy. Biochem. Soc. Trans. 37, 1281-1286.
26. Lee, J.E., Bennett, C.F., and Cooper, T.A. (2012). RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1. Proc. Natl. Acad. Sci. USA 109, 4221-4226.
27. Leroy, O., Dhaenens, C.M., Schraen-Maschke, S., Belarbi, K., Delacourte, A., Andreadis, A., Sablonniere, B., Buee, L., Sergeant, N., and Caillet-Boudin, M.L. (2006a). ETR-3 represses Tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I. J. Neurosci. Res. 84, 852-859.
28. Leroy, O., Wang, J., Maurage, C.A., Parent, M., Cooper, T., Buee, L., Sergeant, N., Andreadis, A., and Caillet-Boudin, M.L. (2006b). Brain-specific change in alternative splicing of Tau exon 6 in myotonic dystrophy type 1. Biochim. Biophys. Acta 1762, 460-467.
29. Lin, X., Miller, J.W., Mankodi, A., Kanadia, R.N., Yuan, Y., Moxley, R.T., Swanson, M.S., and Thornton, C.A. (2006). Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum. Mol. Genet. 15, 2087-2097.
30. Llamusi, B., and Artero, R. (2008). Molecular effects of the CTG repeats in mutant dystrophia myotonica protein kinase gene. Curr. Genomics 9, 509-516.
31. Mahadevan, M.S., Yadava, R.S., Yu, Q., Balijepalli, S., Frenzel-McCardell, C.D., Bourne, T.D., and Phillips, L.H. (2006). Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy. Nat. Genet. 38, 1066-1070.
32. Mankodi, A., Logigian, E., Callahan, L., McClain, C., White, R., Henderson, D., Krym, M., and Thornton, C.A. (2000). Myo-tonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289, 1769-1773.
33. Marteyn, A., Maury, Y., Gauthier, M.M., Lecuyer, C., Vernet, R., Denis, J.A., Pietu, G., Peschanski, M., and Martinat, C. (2011). Mutant human embryonic stem cells reveal neurite and synapse formation defects in type 1 myotonic dystrophy. Cell Stem Cell, 8, 434-444.
34. Mateizel, I., De Temmerman, N., Ullmann, U., Cauffman, G., Sermon, K., Van de Velde, H., De Rycke, M., Degreef, E., Devroey, P., Liebaers, I., and Van Steirteghem, A. (2006). Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Hum. Reprod. 21, 503-511.
35. Maurage, C.A., Udd, B., Ruchoux, M.M., Vermersch, P., Kalimo, H., Krahe, R., Delacourte, A., and Sergeant, N. (2005). Similar brain tau pathology in DM2/PROMM and DM1/Steinert disease. Neurology 65, 1636-1638.
36. Mitake, S., Inagaki, T., Niimi, T., Shirai, T., and Yamamoto, M. (1989). [Development of Alzheimer neurofibrillary changes in two autopsy cases of myotonic dystrophy]. Rinsho Shinkei-gaku 29, 488-492.
37. Mollamohammadi, S., Taei, A., Pakzad, M., Totonchi, M., Seifi-nejad, A., Masoudi, N., and Baharvand, H. (2009). A simple and efficient cryopreservation method for feeder-free dissociated human induced pluripotent stem cells and human embryonic stem cells. Hum. Reprod. 24, 2468-2476.
38. Mulders, S.A., van den Broek, W.J., Wheeler, T.M., Croes, H.J., van Kuik-Romeijn, P., de Kimpe, S.J., Furling, D., Platenburg, G.J., Gourdon, G., Thornton, C.A., Wieringa, B., and Wansink, D.G. (2009). Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy. Proc. Natl. Acad. Sci. USA 106, 13915-13920.
39. Ogata, A., Terae, S., Fujita, M., and Tashiro, K. (1998). Anterior temporal white matter lesions in myotonic dystrophy with intellectual impairment: An MRI and neuropathological study. Neuroradiology 40, 411-415.
40. Orengo, J.P., Chambon, P., Metzger, D., Mosier, D.R., Snipes, G.J., and Cooper, T.A. (2008). Expanded CTG repeats within the DMPK 3¢ UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy. Proc. Natl. Acad. Sci. USA, 105, 2646-2651.
41. Pick, M., Stelzer, Y., Bar-Nur, O., Mayshar, Y., Eden, A., and Benvenisty, N. (2009). Clone-and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Stem Cells 27, 2686-2690.
42. Portwood, M.M., Wicks, J.J., Lieberman, J.S., and Duveneck, M.J. (1986). Intellectual and cognitive function in adults with myotonic muscular dystrophy. Arch. Phys. Med. Rehabil. 67, 299-303.
43. Ranum, L.P., and Cooper, T.A. (2006). RNA-mediated neuro-muscular disorders. Annu. Rev. Neurosci. 29, 259-277.
44. Roig, M., Balliu, P.R., Navarro, C., Brugera, R., and Losada, M. (1994). Presentation, clinical course, and outcome of the congenital form of myotonic dystrophy. Pediatr. Neurol. 11, 208-213.
45. Romeo, V. (2012). Myotonic dystrophy type 1 or Steinert's disease. Adv. Exp. Med. Biol. 724, 239-257.
46. Romeo, V., Pegoraro, E., Ferrati, C., Squarzanti, F., Soraru, G., Palmieri, A., Zucchetta, P., Antunovic, L., Bonifazi, E., Novelli, G., Trevisan, C.P., Ermani, M., Manara, R., and Angelini, C. (2010). Brain involvement in myotonic dystrophies: Neuroi-maging and neuropsychological comparative study in DM1 and DM2. J. Neurol. 257, 1246-1255.
47. Rubinsztein, J.S., Rubinsztein, D.C., McKenna, P.J., Goodburn, S., and Holland, A.J. (1997). Mild myotonic dystrophy is associated with memory impairment in the context of normal general intelligence. J. Med. Genet. 34, 229-233.
48. Schara, U., and Schoser, B.G. (2006). Myotonic dystrophies type 1 and 2: A summary on current aspects. Semin. Pediatr. Neurol. 13, 71-79.
49. Sebastiano, V., Maeder, M.L., Angstman, J.F., Haddad, B., Khayter, C., Yeo, D.T., Goodwin, M.J., Hawkins, J.S., Ramirez, C.L., Batista, L.F., Artandi, S.E., Wernig, M., and Joung, J.K. (2011). In situ genetic correction of the sickle cell anemia mutation in human induced pluripotent stem cells using engineered zinc finger nucleases. Stem Cells 29, 1717-1726.
50. Sergeant, N., Sablonniere, B., Schraen-Maschke, S., Ghestem, A., Maurage, C.A., Wattez, A., Vermersch, P., and Delacourte, A. (2001). Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum. Mol. Genet. 10, 2143-2155.
51. Seznec, H., Agbulut, O., Sergeant, N., Savouret, C., Ghestem, A., Tabti, N., Willer, J.C., Ourth, L., Duros, C., Brisson, E., Fouquet, C., Butler-Browne, G., Delacourte, A., Junien, C., and Gourdon, G. (2001). Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities. Hum. Mol. Genet. 10, 2717-2726.
52. Sistiaga, A., Urreta, I., Jodar, M., Cobo, A.M., Emparanza, J., Otaegui, D., Poza, J.J., Merino, J.J., Imaz, H., Marti-Masso, J.F., and Lopez de Munain, A. (2010). Cognitive/personality pattern and triplet expansion size in adult myotonic dystrophy type 1 (DM1): CTG repeats, cognition and personality in DM1. Psychol. Med. 40, 487-495.
53. Stadtfeld, M., Apostolou, E., Akutsu, H., Fukuda, A., Follett, P., Natesan, S., Kono, T., Shioda, T., and Hochedlinger, K. (2010). Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 465, 175-181.
54. Steyaert, J., Umans, S., Willekens, D., Legius, E., Pijkels, E., de Die-Smulders, C., Van den Berghe, H., and Fryns, J.P. (1997). A study of the cognitive and psychological profile in 16 children with congenital or juvenile myotonic dystrophy. Clin. Genet. 52, 135-141.
55. Suenaga, K., Lee, K.Y., Nakamori, M., Tatsumi, Y., Takahashi, M.P., Fujimura, H., Jinnai, K., Yoshikawa, H., Du, H., Ares, M., Jr., Swanson, M.S., and Kimura, T. (2012). Muscleblind-like 1 knockout mice reveal novel splicing defects in the myotonic dystrophy brain. PLoS One 7, e33218.
56. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and Yamanaka, S. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872.
57. Taneja, K.L., McCurrach, M., Schalling, M., Housman, D., and Singer, R.H. (1995). Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J. Cell Biol. 128, 995-1002.
58. Turetsky, T., Aizenman, E., Gil, Y., Weinberg, N., Shufaro, Y., Revel, A., Laufer, N., Simon, A., Abeliovich, D., and Reubin-off, B.E. (2008). Laser-assisted derivation of human embryonic stem cell lines from IVF embryos after preimplantation genetic diagnosis. Hum. Reprod. 23, 46-53.
59. Vermersch, P., Sergeant, N., Ruchoux, M.M., Hofmann-Radva-nyi, H., Wattez, A., Petit, H., Dwailly, P., and Delacourte, A. (1996). Specific tau variants in the brains of patients with myotonic dystrophy. Neurology 47, 711-717.
60. Wang, G.S., Kearney, D.L., De Biasi, M., Taffet, G., and Cooper, T.A. (2007). Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy. J. Clin. Invest. 117, 2802-2811.
61. Warf, M.B., Nakamori, M., Matthys, C.M., Thornton, C.A., and Berglund, J.A. (2009). Pentamidine reverses the splicing defects associated with myotonic dystrophy. Proc. Natl. Acad. Sci. USA 106, 18551-18556.
62. Wheeler, T.M., Sobczak, K., Lueck, J.D., Osborne, R.J., Lin, X., Dirksen, R.T., and Thornton, C. A. (2009). Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA. Science 325, 336-339.
63. Wheeler, T.M., Leger, A.J., Pandey, S.K., MacLeod, A.R., Naka-mori, M., Cheng, S.H., Wentworth, B.M., Bennett, C.F., and Thornton, C.A. (2012). Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature 488, 111-115.
64. Yoshimura, N., Otake, M., Igarashi, K., Matsunaga, M., Takebe, K., and Kudo, H. (1990). Topography of Alzheimer's neuro-fibrillary change distribution in myotonic dystrophy. Clin. Neuropathol. 9, 234-239.
65. Zhao, T., Zhang, Z.N., Rong, Z., and Xu, Y. (2011). Im-munogenicity of induced pluripotent stem cells. Nature 474, 212-215.
66. Zou, J., Maeder, M.L., Mali, P., Pruett-Miller, S.M., Thibodeau-Beganny, S., Chou, B.K., Chen, G., Ye, Z., Park, I.H., Daley, G.Q., Porteus, M.H., Joung, J.K., and Cheng, L. (2009). Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell 5, 97-110.
67. Zou, J., Mali, P., Huang, X., Dowey, S.N., and Cheng, L. (2011). Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease. Blood 118, 4599-4608.